PURPOSE: To compare the potency of mesenchymal stem cells between the cells derived from the subacromial bursa to concentrated bone marrow aspirate (cBMA) taken from patients undergoing rotator cuff (RC) repair. METHODS: Subacromial bursa and cBMA were harvested arthroscopically from 13 patients (age 57.4 ± 5.2 years, mean ± standard deviation) undergoing arthroscopic primary RC repair. Bone marrow was aspirated from the proximal humerus and concentrated using an automated system (Angel System; Arthrex). Subacromial bursa was collected from 2 sites (over the RC tendon and muscle) and digested with collagenase to isolate a single cellular fraction. Proliferation, number of colony-forming units, differentiation potential, and gene expression were compared among the cells derived from each specimen. RESULTS: The cells derived from subacromial bursa showed significantly higher proliferation compared with the cells derived from cBMA after 5, 7, and 10 days (P = .018). Regarding colony-forming units, the subacromial bursa had significantly more colonies than cBMA (P = .002). Subacromial bursal cells over the RC tendon produced significantly more colonies than cells over both the RC muscle and cBMA (P = .033 and P = .028, respectively). Moreover, when compared with cBMA, cells derived from subacromial bursa showed significantly higher differentiation ability and higher gene expression indicative of chondrogenesis, osteogenesis, and adipogenesis. CONCLUSION: The subacromial bursa is an easily accessible tissue that can be obtained during RC repair, with significant pluripotent stem cell potency for tendon healing. Compared with cBMA taken from the proximal humerus, bursal cells showed significantly increased differentiation ability and gene expression over time. CLINICAL RELEVANCE: Failed RC repairs have been partly attributed to a poor healing environment. Biologic augmentation of the repair site may help increase healing potential and incorporation of the cuff at the tendon-bone interface.
PURPOSE: To compare the potency of mesenchymal stem cells between the cells derived from the subacromial bursa to concentrated bone marrow aspirate (cBMA) taken from patients undergoing rotator cuff (RC) repair. METHODS: Subacromial bursa and cBMA were harvested arthroscopically from 13 patients (age 57.4 ± 5.2 years, mean ± standard deviation) undergoing arthroscopic primary RC repair. Bone marrow was aspirated from the proximal humerus and concentrated using an automated system (Angel System; Arthrex). Subacromial bursa was collected from 2 sites (over the RC tendon and muscle) and digested with collagenase to isolate a single cellular fraction. Proliferation, number of colony-forming units, differentiation potential, and gene expression were compared among the cells derived from each specimen. RESULTS: The cells derived from subacromial bursa showed significantly higher proliferation compared with the cells derived from cBMA after 5, 7, and 10 days (P = .018). Regarding colony-forming units, the subacromial bursa had significantly more colonies than cBMA (P = .002). Subacromial bursal cells over the RC tendon produced significantly more colonies than cells over both the RC muscle and cBMA (P = .033 and P = .028, respectively). Moreover, when compared with cBMA, cells derived from subacromial bursa showed significantly higher differentiation ability and higher gene expression indicative of chondrogenesis, osteogenesis, and adipogenesis. CONCLUSION: The subacromial bursa is an easily accessible tissue that can be obtained during RC repair, with significant pluripotent stem cell potency for tendon healing. Compared with cBMA taken from the proximal humerus, bursal cells showed significantly increased differentiation ability and gene expression over time. CLINICAL RELEVANCE: Failed RC repairs have been partly attributed to a poor healing environment. Biologic augmentation of the repair site may help increase healing potential and incorporation of the cuff at the tendon-bone interface.
Authors: Daichi Morikawa; Matthew R LeVasseur; S Brandon Luczak; Michael R Mancini; Nicholas Bellas; Mary Beth R McCarthy; Mark P Cote; Daniel P Berthold; Lukas N Muench; Augustus D Mazzocca Journal: Arthrosc Sports Med Rehabil Date: 2021-05-14
Authors: Lukas N Muench; Colin L Uyeki; Michael R Mancini; Daniel P Berthold; Mary Beth McCarthy; Augustus D Mazzocca Journal: Arthrosc Tech Date: 2021-08-02
Authors: Lukas N Muench; Lisa Tamburini; Danielle Kriscenski; Arthur Landry; Daniel P Berthold; Cameron Kia; Mark P Cote; Mary Beth McCarthy; Augustus D Mazzocca Journal: Arthrosc Sports Med Rehabil Date: 2021-03-22
Authors: Lukas N Muench; Cameron Kia; Daniel P Berthold; Colin Uyeki; Alexander Otto; Mark P Cote; Mary Beth McCarthy; Knut Beitzel; Robert A Arciero; Augustus D Mazzocca Journal: Arthrosc Sports Med Rehabil Date: 2020-10-05
Authors: Matthew R LeVasseur; Benjamin C Hawthorne; Michael R Mancini; Mary Beth R McCarthy; Ian J Wellington; Mark P Cote; Olga Solovyova; Vincent J Williams; Augustus D Mazzocca Journal: Arthrosc Sports Med Rehabil Date: 2021-09-08
Authors: Ian J Wellington; Benjamin C Hawthorne; James C Messina; Matthew R LeVasseur; Mary Beth McCarthy; Mark P Cote; Augustus D Mazzocca Journal: J Clin Med Date: 2022-02-25 Impact factor: 4.241
Authors: Lukas N Muench; Danielle Kriscenski; Lisa Tamburini; Daniel P Berthold; Marco-Christopher Rupp; Michael R Mancini; Mark P Cote; Mary Beth McCarthy; Augustus D Mazzocca Journal: Arthrosc Sports Med Rehabil Date: 2021-11-14